A Form 4 filed on August 7, 2026 discloses that Maggie Yuen, a director of AtriCure, Inc. (NASDAQ: ATRC), sold 3,500 shares of common stock on August 5, 2026 at a weighted average price of $38.42 per share.

Key Highlights

  • Reporting person: Maggie Yuen, identified as a Director of AtriCure, Inc.
  • Shares sold: 3,500 shares of common stock disposed of (transaction code S) on August 5, 2026.
  • Weighted average price: $38.42 per share, with individual trades ranging from $38.37 to $38.43 per share.
  • Remaining holdings: 14,015 shares of common stock held directly following the reported transaction.
  • Multiple trades: The transaction was executed across multiple trades; full details are available upon request to the SEC, the issuer, or a security holder.

AtriCure Director Share Sale: Transaction Details

According to the filing, Maggie Yuen, serving as a Director at AtriCure, Inc., reported the disposition of 3,500 shares of AtriCure common stock on August 5, 2026. The transaction is coded "S," indicating a sale. The filing states the weighted average sales price was $38.42 per share, with the individual trades in the transaction executed at prices ranging from $38.37 to $38.43 per share.

The filing discloses that following the reported sale, Yuen directly beneficially owns 14,015 shares of AtriCure common stock. No derivative securities transactions were reported in Table II of the filing. The form was filed by one reporting person and covers a single transaction line for directly held common stock.

The filing includes a note that Yuen "undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected." The form was signed by Maggie Yuen and dated August 7, 2026.

What Was Disclosed

The filing reports a single open-market sale of 3,500 shares of AtriCure common stock by Director Maggie Yuen on August 5, 2026, at a weighted average price of $38.42, leaving her with a direct beneficial ownership of 14,015 shares.